Moving Past Quinone-Methides: Recent Advances Toward Minimizing Electrophilic Byproducts from COS/HS Donors.

Michael D Pluth

Journal: Current topics in medicinal chemistry 2022;21(32):2882-2889

PMID: 34161211

Abstract

Hydrogen sulfide (HS) is an important biomolecule that plays key signaling and protective roles in different physiological processes. With goals of advancing both the available research tools and the associated therapeutic potential of HS, researchers have developed different methods to deliver HS on demand in different biological contexts. A recent approach to develop such donors has been to design compounds that release carbonyl sulfide (COS), which is quickly converted to HS in biological systems by the ubiquitous enzyme carbonic anhydrase (CA). Although highly diversifiable, many approaches using this general platform release quinone methides or related electrophiles after donor activation. Many such electrophiles are likely scavenged by water, but recent efforts have also expanded alternative approaches that minimize the formation of electrophilic byproducts generated after COS release. This mini-review focuses specifically on recent examples of COS-based HS donors that do no generate quinone methide byproducts after donor activation.

Copyright© Bentham Science Publishers; For any queries, please email at [email protected].

Address: Department of Chemistry and Biochemistry, Materials Science Institute, Knight Campus for Accelerating Scientific Impact, Institute of Molecular Biology. University of Oregon. Eugene, OR,United States.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.